Tatsuya Koike

Hirano-honmachi, 5470044, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Structural remission rate and factors associated with radiographic progression in patients with rheumatoid arthritis treated with sarilumab in clinical practice.

Structural remission rate and factors associated with radiographic progression in patients with rheumatoid arthritis treated with sarilumab in clinical practice.

Journal: Clinical rheumatology

Published: December 05, 2025

Biological/targeted synthetic disease-modifying antirheumatic drugs improve not only muscle mass but also phase angle in patients with rheumatoid arthritis.

Biological/targeted synthetic disease-modifying antirheumatic drugs improve not only muscle mass but also phase angle in patients with rheumatoid arthritis.

Journal: Clinical rheumatology

Published: August 10, 2025

Glucocorticoid usage is involved in the improvement and development of frailty in patients with rheumatoid arthritis: Results from the PRESENT study.

Glucocorticoid usage is involved in the improvement and development of frailty in patients with rheumatoid arthritis: Results from the PRESENT study.

Journal: Geriatrics & gerontology international

Published: April 15, 2025

Coffee consumption may suppress development of metabolic syndrome in patients with rheumatoid arthritis-TOMORROW study.

Coffee consumption may suppress development of metabolic syndrome in patients with rheumatoid arthritis-TOMORROW study.

Journal: Modern rheumatology

Published: November 26, 2024

Change of autoantibody levels in established rheumatoid arthritis patients treated by biological disease-modifying anti-rheumatic drugs -the AIRTIGHT study.

Change of autoantibody levels in established rheumatoid arthritis patients treated by biological disease-modifying anti-rheumatic drugs -the AIRTIGHT study.

Journal: Journal of rheumatic diseases

Published: November 06, 2024

Biologic and targeted synthetic disease-modifying anti-rheumatic drugs improve body composition in rheumatoid arthritis patients more than conventional synthetic disease-modifying anti-rheumatic drugs: Results from the PRESENT study.

Biologic and targeted synthetic disease-modifying anti-rheumatic drugs improve body composition in rheumatoid arthritis patients more than conventional synthetic disease-modifying anti-rheumatic drugs: Results from the PRESENT study.

Journal: International journal of rheumatic diseases

Published: July 02, 2024

Ultrasonographic Synovitis Is Associated with the Development of Joint Destruction in Patients with Psoriatic Arthritis.

Ultrasonographic Synovitis Is Associated with the Development of Joint Destruction in Patients with Psoriatic Arthritis.

Journal: Journal of personalized medicine

Published: May 14, 2024

Efficacy and safety of Janus kinase inhibitors in patients with difficult-to-treat rheumatoid arthritis.

Efficacy and safety of Janus kinase inhibitors in patients with difficult-to-treat rheumatoid arthritis.

Journal: Modern rheumatology

Published: April 05, 2024

Comparison of creatine kinase elevation caused by Janus kinase inhibitors and interleukin-6 inhibitors in patients with rheumatoid arthritis: A propensity score-matched study.

Comparison of creatine kinase elevation caused by Janus kinase inhibitors and interleukin-6 inhibitors in patients with rheumatoid arthritis: A propensity score-matched study.

Journal: Archives of rheumatology

Published: January 11, 2024

Which should be first: biologic DMARDs or Janus kinase inhibitors?

Which should be first: biologic DMARDs or Janus kinase inhibitors?

Journal: Rheumatology (Oxford, England)

Published: October 31, 2022

Comparison of clinical and radiographic results of mobile-bearing total ankle arthroplasty between osteoarthritis and rheumatoid arthritis.

Comparison of clinical and radiographic results of mobile-bearing total ankle arthroplasty between osteoarthritis and rheumatoid arthritis.

Journal: Modern rheumatology

Published: July 08, 2022

Impact of disease burden or inflammation on nutritional assessment by the GLIM criteria in female patients with rheumatoid arthritis.

Impact of disease burden or inflammation on nutritional assessment by the GLIM criteria in female patients with rheumatoid arthritis.

Journal: Clinical nutrition ESPEN

Published: June 17, 2022

Showing 1-12 of 61

Last Updated: 09/26/2026